NUVB · NYSE · Biotechnology

Nuvation Bio (NUVB)

Develops cancer medicines led by IBTROZI and a focused oncology pipeline.

$6.10
After hours0.00 (0.00%)
At close$6.10(+0.49%)
  1. Nuvation Bio (NUVB) Upgraded to Buy: Here's Why

    Zacks Investment ResearchPrice target